AcelRx Pharmaceuticals, Inc.
SIMPLIFYING ACUTE PAIN RELIEF
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. In November of 2018, its lead product candidate DSUVIA® (sufentanil sublingual tablet 30 mcg) was approved by the U.S. Food and Drug Administration.
Brands: DSUVIA
Zalviso
Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Appointment Request
Blocked Timeslot
Restricted Timeslot
For technical assistance with this webpage, please contact
support.